Showing results (1211-1220 of 1,484) with videos related to

Sort By:
Pageof 149
Blood Cells, Molecules & Diseases|November 6, 2004
WT1-targeted immunotherapy of leukaemiaS Xue, L Gao, R Gillmore, et al.
Inorganic Chemistry|October 3, 2013
Heteroleptic copper(I) complexes prepared from phenanthroline and bis-phosphine ligandsAdrien Kaeser, Meera Mohankumar, John Mohanraj, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 20, 2007
Monoclonal T-cell receptors: new reagents for cancer therapyHans J Stauss, Michela Cesco-Gaspere, Sharyn Thomas, et al.
Nature Materials|April 10, 2019
Ultrafast transition between exciton phases in van der Waals heterostructuresP Merkl, F Mooshammer, P Steinleitner, et al.
OTA International : the Open Access Journal of Orthopaedic Trauma|May 3, 2021
Knowledge deficits and barriers to performing soft-tissue coverage procedures: An analysis of participants in an orthopaedic surgical skills training course in MexicoPatrick D Albright, Madeline C Mackechnie, J Hunter Jackson, et al.
Plos One|February 23, 2012
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancerSatoshi Inoue, Rameshwar Patil, Jose Portilla-Arias, et al.
Science Translational Medicine|December 20, 2023
Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effectsMariano Prado-Acosta, Seihwan Jeong, Alberto Utrero-Rico, et al.
Urology Practice|May 5, 2023
Characteristics of Online Crowdfunding Campaigns for Urological Cancers in the United StatesJordan T Holler, Nizar Hakam, Behnam Nabavizadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2014
CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptorSara Ghorashian, Pedro Veliça, Ignatius Chua, et al.
Pageof 149